Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Spec Oper Med ; 17(4): 49-51, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29256194

RESUMO

BACKGROUND: Human-animal interactions in the form of animal-assisted therapy (AAT) have become common in both civilian and military health care facilities. Evidence supports AAT as a beneficial therapeutic alternative for patients with physical disabilities and psychological disorders. Few studies have been conducted in the civilian health care setting to evaluate staff attitudes regarding the impact of an AAT program on behavioral health (BH) patients. To our knowledge, no research has examined staff attitudes on the impact and effectiveness of AAT on active-duty Servicemembers in a BH program at a military facility. METHODS: At the completion of a year-long AAT dog program and after institutional review board exemption, an anonymous, six-question survey was used to examine staff attitudes (n = 29) regarding the impact and continuation of the program with military BH patients. RESULTS: Most staff members (86%) believed the AAT dog program had a positive impact on the BH patients, including improved patient mood, greater patient relaxation, improved patient attitude toward therapy, and increased social interactions among patients. All the staff reported a desire to continue the program at the military facility. CONCLUSION: Most BH staff thought the year-long AAT dog program had a positive impact on patients. All staff supported continuation of the program.


Assuntos
Terapia Assistida com Animais , Atitude do Pessoal de Saúde , Cães , Transtornos Mentais/terapia , Militares/psicologia , Animais , Humanos , Inquéritos e Questionários , Estados Unidos
2.
PLoS One ; 10(5): e0128382, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26020250

RESUMO

A major obstacle in prioritizing species or habitats for conservation is the degree of unrecognized diversity hidden within complexes of morphologically similar, "cryptic" species. Given that amphibians are one of the most threatened groups of organisms on the planet, our inability to diagnose their true diversity is likely to have significant conservation consequences. This is particularly true in areas undergoing rapid deforestation, such as Southeast Asia. The Southeast Asian genus Leptolalax is a group of small-bodied, morphologically conserved frogs that inhabit the forest-floor. We examined a particularly small-bodied and morphologically conserved subset, the Leptolalax applebyi group, using a combination of molecular, morphometric, and acoustic data to identify previously unknown diversity within. In order to predict the geographic distribution of the group, estimate the effects of habitat loss and assess the degree of habitat protection, we used our locality data to perform ecological niche modelling using MaxEnt. Molecular (mtDNA and nuDNA), acoustic and subtle morphometric differences revealed a significant underestimation of diversity in the L. applebyi group; at least two-thirds of the diversity may be unrecognised. Patterns of diversification and microendemism in the group appear driven by limited dispersal, likely due to their small body size, with several lineages restricted to watershed basins. The L. applebyi group is predicted to have historically occurred over a large area of the Central Highlands of Vietnam, a considerable portion of which has already been deforested. Less than a quarter of the remaining forest predicted to be suitable for the group falls within current protected areas. The predicted distribution of the L. applebyi group extends into unsurveyed watershed basins, each potentially containing unsampled diversity, some of which may have already been lost due to deforestation. Current estimates of amphibian diversity based on morphology alone are misleading, and accurate alpha taxonomy is essential to accurately prioritize conservation efforts.


Assuntos
Conservação dos Recursos Naturais , Ecossistema , Espécies em Perigo de Extinção , Modelos Biológicos , Ranidae/fisiologia , Animais , Vietnã
3.
J Am Osteopath Assoc ; 107(9 Suppl 5): ES17-20, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17908826

RESUMO

Not all patients are treated equally for their pain with some therefore being undertreated. Discrepancies still exist in the way physicians treat special populations of patients such as racial minorities, women, and substance abusers. All healthcare providers need to be aware of the not so readily apparent disparities resulting from stereotyping, bias, ageism, and socioeconomic considerations. Physicians can best provide appropriate and equal care by following pain management guidelines; however, they may receive contradictory information and be apprehensive about prescribing opioids, especially to substance abusers. In this "refreshed" article, the authors describe patient encounters with patients of color and offer some goals for removing inequality and inequity from clinical settings.


Assuntos
Analgésicos/uso terapêutico , Artralgia/tratamento farmacológico , Atenção à Saúde , Dor Lombar/tratamento farmacológico , Relações Médico-Paciente , Adulto , Articulação do Tornozelo , Artralgia/psicologia , Tomada de Decisões , Prescrições de Medicamentos , Feminino , Humanos , Dor Lombar/complicações , Dor Lombar/psicologia , Pessoa de Meia-Idade , Medição da Dor , Transtornos Relacionados ao Uso de Substâncias/complicações , Transtornos Relacionados ao Uso de Substâncias/psicologia
4.
J Am Osteopath Assoc ; 107(9 Suppl 5): ES21-6, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17908827

RESUMO

As osteopathic physicians care for patients with complaints of pain, they commonly prescribe controlled substances. The use of these agents presents special challenges for providers, patients, and communities. The US Drug Enforcement Administration (DEA) has provided testimony to the US Congress in regard to the growing problem of diversion and misuse of such medications. Joseph T. Rannazzisi, the deputy assistant administrator in the Office of Diversion Control, appeared before the House Government Reform Committee's Subcommittee on Criminal Justice, Drug Policy, and Human Resources on July 26, 2006.


Assuntos
Analgésicos Opioides/efeitos adversos , Prescrições de Medicamentos/normas , Controle de Medicamentos e Entorpecentes/tendências , Transtornos Relacionados ao Uso de Opioides/prevenção & controle , Dor Intratável/tratamento farmacológico , Analgésicos Opioides/uso terapêutico , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Humanos , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Estados Unidos/epidemiologia
5.
J Am Osteopath Assoc ; 106(3 Suppl 1): S14-8, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16729556

RESUMO

Multivalent prophylactic human papillomavirus (HPV) vaccines currently in the late stages of clinical testing are safe, immunogenic, and efficacious; and phase 3 tests of a quadrivalent vaccine show that it is 100% effective at preventing HPV types 16 and 18-associated cervical intraepithelial neoplasia grades 2 and 3, adenocarcinoma in situ, and cervical cancer through 2 years of postvaccination follow-up. These vaccines promise to reduce the burden of HPV-related disease. Realizing the full benefit of these vaccines will require a vaccination program that addresses the needs and concerns of healthcare providers, parents, and young adolescent patients who will be involved in the vaccine decisionmaking process. Osteopathic physicians, by virtue of their dedication to holistic care, are in an optimal position to play a key role in facilitating acceptance of these vaccines among potential vaccinees and their parents and guardians.


Assuntos
Papillomaviridae/imunologia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus , Aceitação pelo Paciente de Cuidados de Saúde , Vacinas Virais , Adolescente , Adulto , Atitude do Pessoal de Saúde , Custos de Medicamentos , Feminino , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , Vacinas Virais/economia
6.
J Am Osteopath Assoc ; 105(6 Suppl 3): S14-7, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16118357

RESUMO

Despite efforts targeted at physicians for improving the way in which they manage pain, discrepancies still abound in how they treat certain patients for this condition. Special populations of patients such as racial minorities, women, and substance abusers are victims of deficiencies in pain management and suffer needlessly. Healthcare providers need to be aware of disparities that may not be readily apparent. To provide appropriate care, physicians need to follow pain management guidelines; however, they receive contradictory information on how to treat patients in pain, and they may be apprehensive about prescribing opioids. Recognizing that pain is one of the most frequent reasons a patient may see a physician, it is important to recognize the healthcare disparities in managing pain as well as the barriers to providing appropriate treatment for pain. Only when physicians acknowledge disparities and barriers can they begin to evaluate and improve on their own practices of pain management.


Assuntos
Analgésicos/uso terapêutico , Atenção à Saúde , Dor/tratamento farmacológico , Qualidade da Assistência à Saúde , Atitude do Pessoal de Saúde , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...